Clinical Trial Update: Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of letermovir with standard-of-care antivirals for cytomegalovirus infection in lung transplant recipient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Letermovir (letermovir)

Snippet

Sponsor: University Health Network, Toronto | Conditions: CMV, Lung Transplant Recipient | Phase 4 | Status: RECRUITING